Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer

Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer

Kai Li,1 Fuchao Chen,2 Huijuan Xie3 1Department of Pathology, 2Department of Clinical Pharmacy, 3Department of Hyperbaric Oxygen, Dongfeng Hospital, Hubei University of Medicine, Shiyan, People’s Republic of China Abstract: Neoadjuvant chemotherapy (NACT) has been an increasingly used th...

Full description

Bibliographic Details
Main Authors:	Li K, Chen F, Xie H
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-06-01
Series:	OncoTargets and Therapy
Subjects:	neoadjuvant chemotherapy gastric cancer Tregs FOXP3 GARP
Online Access:	https://www.dovepress.com/decreased-foxp3-and-garp-tregs-to-neoadjuvant-chemotherapy-associated--peer-reviewed-article-OTT

Similar Items

GARP and GARP-Treated tDC Prevented the Formation of Atherosclerotic Plaques in ApoE−/- Mice
by: Cai Y, et al.
Published: (2021-07-01)

Heme Oxygenase-1 Restores Impaired GARP+CD4+CD25+ Regulatory T Cells from Patients with Acute Coronary Syndrome by Upregulating LAP and GARP Expression on Activated T Lymphocytes
by: Yuzhou Liu, et al.
Published: (2015-01-01)

Platelet-Derived GARP Induces Peripheral Regulatory T Cells—Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis
by: Niklas Zimmer, et al.
Published: (2020-12-01)

GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer
by: Sutian Jiang, et al.
Published: (2021-08-01)

Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer
by: Alessandra Metelli, et al.
Published: (2018-02-01)

Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS
by: Qiong Wang, et al.
Published: (2020-01-01)

Corrigendum: Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS
by: Qiong Wang, et al.
Published: (2021-03-01)

The Correlation Between Computed Tomography Volumetry and Prognosis of Advanced Gastric Cancer Treated with Neoadjuvant Chemotherapy
by: Chen C, et al.
Published: (2020-02-01)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
by: Juan Sun, et al.
Published: (2021-04-01)

FOXP3+ Treg cells and its gender bias in autoimmune diseases
by: Jia eNie, et al.
Published: (2015-09-01)

Overall Survival Results with Surgical Treatment After Neoadjuvant Chemotherapy in Local Invasive Gastric Cancers
by: Gökhan Ertuğrul
Published: (2019-04-01)

Clinicopathological factors affecting the effect of neoadjuvant chemotherapy in patients with gastric cancer
by: Lin Jiang, et al.
Published: (2021-02-01)

Neoadjuvant chemotherapy of epirobicin, oxaliplatin, capecitabine regimen in patients with advanced gastric cancer: a two year study
by: Samiei F, et al.
Published: (2012-10-01)

Foxp3 Molecular Dynamics in Treg in Juvenile Idiopathic Arthritis
by: Alastair Copland, et al.
Published: (2018-10-01)

Neoadjuvant systemic therapy for patients with gastric cancer: Current concepts and outcomes
by: Fatih Selcukbiricik, et al.
Published: (2016-01-01)

Foxp3 Instability Helps tTregs Distinguish Self and Non-self
by: Zhongmei Zhang, et al.
Published: (2019-09-01)

Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
by: David Borg, et al.
Published: (2018-10-01)

The value of restaging CT following neoadjuvant chemotherapy for resectable gastric cancer. A population-based study
by: Alina Desiree Sandø, et al.
Published: (2021-07-01)

Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy
by: Qing Hu, et al.
Published: (2021-06-01)

Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer
by: Ren Hui, et al.
Published: (2011-09-01)

Reduced frequencies of Foxp3+GARP+ regulatory T cells in COPD patients are associated with multi-organ loss of tissue phenotype
by: Duan, X., et al.
Published: (2022)

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series
by: Christina Hadzitheodorou, et al.
Published: (2017-04-01)

Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer
by: Shen-Bao Hu, et al.
Published: (2019-01-01)

Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy
by: Xiaolong Tang, et al.
Published: (2019-08-01)

The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: A multicenter randomized clinical trial
by: Qun Zhao, et al.
Published: (2020-08-01)

Comparison of the cancer cell-killing effect of the DOS scheme and the SOX scheme for neoadjuvant chemotherapy for gastric cancer
by: Ya-Ni Chen, et al.
Published: (2017-07-01)

Searching for the Achilles heel of FOXP3
by: Teresa eLozano, et al.
Published: (2013-12-01)

Resting and Activated Natural Tregs Decrease in the Peripheral Blood of Patients with Atherosclerosis
by: Mohammadreza Yazdani, et al.
Published: (2016-12-01)

Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
by: Zhi Zhu, et al.
Published: (2020-09-01)

Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
by: Yinkui Wang, et al.
Published: (2020-12-01)

Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3
by: Angelika Schmidt, et al.
Published: (2018-05-01)

Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
by: Masato Kondo, et al.
Published: (2020-06-01)

Is Pathologic Complete Response the Surrogate in Primary Gastric Angiosarcoma Undergoing Doxorubicin-Based Neoadjuvant Chemotherapy? A Case Report
by: Zheng CH, et al.
Published: (2020-12-01)

A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
by: Wang Y, et al.
Published: (2020-09-01)

Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis
by: Zhi-Feng Miao, et al.
Published: (2018-01-01)

15-PGDH Expression in Gastric Cancer: A Potential Role in Anti-Tumor Immunity
by: Li Y, et al.
Published: (2020-08-01)

Stability and Maintenance of Foxp3+ Treg Cells in Non-lymphoid Microenvironments
by: Thomas Korn, et al.
Published: (2019-11-01)

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part I: Treg properties and functions
by: Bogusław Nedoszytko, et al.
Published: (2017-07-01)

A Machine Learning Model for Predicting a Major Response to Neoadjuvant Chemotherapy in Advanced Gastric Cancer
by: Yonghe Chen, et al.
Published: (2021-06-01)

GARP: A Key Target to Evaluate Tumor Immunosuppressive Microenvironment
by: Alexanne Bouchard, et al.
Published: (2021-08-01)